Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 11, Issue 9 pp 2898—2910
miR-495 inhibits the growth of fibroblasts in hypertrophic scars
Figure 4. FAK is crucial to the inhibitory effect of miR-495 on HSFs growth. (A) MTT assays showing the effects of si-FAK and miR-495 inhibitor on HSF proliferation. Data are presented as the mean ± SEM. ** P< 0.01 si-FAK vs. control, ## P< 0.01 si-FAK+miR-495 inhibitor vs. si-FAK. (B) AV-PI assays showing the effects of si-FAK and miR-495 inhibitor on HSF apoptosis. (C, D) Following transfection of HSFs with si-FAK or si-FAK plus miR-495 inhibitor, expression of FAK, FAKp-Tyr397, cyclin D1, bcl-2, bax and COL1A were detected using western blotting and real-time PCR. Data are presented as the mean ± SEM. ** P< 0.01 si-FAK vs. control, ## P< 0.01 si-FAK+miR-495 inhibitor vs. si-FAK.